Instrumento Inactivo

Otros idiomas InspireMD Inc Nyse

Acciones

US45779A5074

Precio de cierre Nyse Otros sitios de cotización
- ^USD	-

14/05	Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024
13/05	InspireMD, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024	14/05
InspireMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024	06/03
InspireMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
InspireMD Gets CE Mark Recertification From the European Union	31/01
InspireMD, Inc. Announces Appointment of Pete Ligotti as Executive Vice President and General Manager of North America	03/01
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions	27/11
Transcript : InspireMD, Inc., Q3 2023 Earnings Call, Nov 06, 2023	06/11
InspireMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Inspiremd, Inc. Presents Positive 30-Day Follow-Up Results from the C-Guard®? U.S. Investigational Device Exemption Clinical Trial	01/11
InspireMD, Inc. Supports CMS? Final National Coverage Determination Expanding Coverage of Carotid Stenting to Include Both Asymptomatic and Standard Risk Patients	12/10/23
InspireMD, Inc. Announces Management Appointments	03/10/23
Transcript : InspireMD, Inc., Q2 2023 Earnings Call, Aug 08, 2023	08/08/23
InspireMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/08/23
InspireMD, Inc. Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption Clinical Trial	26/06/23
INSPIREMD, INC. : Piper Sandler réitère son opinion positive sur le titre	12/06/23
INSPIREMD, INC. : Alliance Global Partners réitère son opinion positive sur le titre	17/05/23
Insider Buy: Inspiremd	16/05/23
Insider Buy: Inspiremd	16/05/23
Insider Buy: Inspiremd	16/05/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas InspireMD Inc Nyse

Acciones

US45779A5074

Otros idiomas

Filtros